| CAS | Product Name | MF |
|
600171-70-8
|
H-ALA-SER-GLY-PRO-LEU-GLY-THR-LEU-ALA-GLU-GLU-LEU-SER-SER-TYR-SER-ARG-ARG-LYS-GLY-GLY-PHE-SER-PHE-ARG-PHE-NH2
|
C126H195N37O37
|
|
440124-25-4
|
3-Bromo-5-chloropyrazine-2-carbonitrile
|
C5HBrClN3
|
|
1190-63-2
|
CETYL STEARATE
|
C34H68O2
|
|
6736-40-9
|
N-Methyl-5-methylamino-1H-imidazole-4-carboxamide
|
C6H10N4O
|
|
1447693-83-5
|
Aprepitant Impurity 15
|
C20H19ClF7NO2
|
|
26173-92-2
|
5-methyl-1H-pyrrole-2-carbonitrile(SALTDATA: FREE)
|
C6H6N2
|
|
761441-54-7
|
lithium 4,5-dicyano-2-(trifluoromethyl)imidazol-1-ide
|
C6F3LiN4
|
|
1375470-88-4
|
(3S,5S,6R)-3-amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one hydrochloride
|
C14H18ClF3N2O
|
|
1951-38-8
|
2-METHOXYISOPHTHALIC ACID
|
C9H8O5
|
|
1262412-13-4
|
1-Boc-3-aMino-3-azetidinecarboxylic acid
|
C9H16N2O4
|
|
1621019-96-2
|
9-mesityl-10-phenylacridin-10-ium tetrafluoroborate
|
C28H24BF4N
|
|
3089-19-8
|
N-(2-(2-OXO-1-IMIDAZOLIDINYL)ETHYL)-METH ACRYLAMIDE, TECH.
|
C9H15N3O2
|
|
1118-15-6
|
1,1,3,3-tetramethyldisiloxane-1,3-diol
|
C4H14O3Si2
|
|
1467015-10-6
|
Sunitinib Impurity 1
|
C18H18FN3O2
|
|
2212020-52-3
|
GLP-1 receptor agonist 1
|
C48H48F2N10O5
|
|
1458640-32-8
|
Carbidopa impurity F
|
C12H18N2O4
|
|
2146135-87-5
|
((2R,3S,4R,5R,6S)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl) methyl)-4-methylphenyl)-3,4,5-trihydroxytetrahydro- 2H-pyran-2-yl)methyl acetate
|
C26H27FO6S
|
|
1056874-46-4
|
Bis(2-(3,5-dimethylphenyl)quinoline-C2,N')(acetylacetonato)iridium(III)
|
C39H35IrN2O2
|
|
114213-69-3
|
N-Methyl Gatifloxacin
|
C20H24FN3O4
|
|
956494-20-5
|
Biotin-PEG11-Azide
|
C34H64N6O13S
|
|
141801-03-8
|
IL-1 RECEPTOR PEPTIDE (HUMAN)
|
C47H88N14O12S
|
|
138516-31-1
|
Bisindolylmaleimide VIII acetate salt
|
C24H22N4O2
|
|
118476-85-0
|
DALDA (BCH-150)
|
C30H45N9O5
|
|
62522-93-4
|
N-(4-Fluorobenzoyl)-L-proline
|
C12H12FNO3
|
|
1501980-29-5
|
Trans-5-(Benzyloxyamino)piperidine-2-carboxylic acid
|
C13H18N2O3
|
|
103877-02-7
|
5-O-Desmethyl Omeprazole Sulfide
|
C16H17N3O2S
|
|
500170-27-4
|
(DEAMINO-CYS1,BETA-CYCLOHEXYL-ALA4,ARG8)-VASOPRESSIN
|
C50H71N13O11S2
|
|
66382-56-7
|
Z-ALA-PRO-PNA
|
C22H24N4O6
|
|
95262-10-5
|
3-(4-fluorophenylaMino)-3-oxopropanoic acid
|
C9H8FNO3
|
|
56792-69-9
|
(3,3-DIMETHYL-1-BUTYNE)DICOBALT HEXACARBONYL
|
C12H10Co2O6
|
|
942-54-1
|
2-(4-methoxyphenyl)propanoic acid
|
C10H12O3
|
|
16952-65-1
|
Pyrido[4,3-d]pyriMidine-2,4(1H,3H)-dione
|
C7H5N3O2
|
|
846023-55-0
|
4-Methoxy-3-(3-(4-Methylpiperazin-1-yl)propoxy)aniline
|
C15H25N3O2
|
|
1886-34-6
|
4-AMino-5-(forMaMidoMethyl)-2-MethylpyriMidine
|
C7H10N4O
|
|
25130-29-4
|
5-CHLOROCYTIDINE
|
C9H12ClN3O5
|
|
147123-67-9
|
3-Chloro-2-Cyanothiophene
|
C5H2ClNS
|
|
1377584-27-4
|
ethyl imidazo[1,5-a]pyrazine-1-carboxylate
|
C9H9N3O2
|
|
52092-12-3
|
Beclomethasone Dipropionate Impurity
|
C28H36O6
|
|
1088543-62-7
|
AZP-531
|
C40H63N15O13
|
|
127733-98-6
|
Tetraammineplatinum(II) hydrogen phosphate
|
H13N4O4PPt
|
|
2289691-01-4
|
MYCi975
|
C25H16Cl2F6N2O2
|
|
102992-39-2
|
(D-SER4)-TRIPTORELIN
|
C64H82N18O13
|
|
871583-16-3
|
METHYL 4-METHOXY-5-AZAINDOLE-2-CARBOXYLATE
|
C10H10N2O3
|
|
1563006-28-9
|
Vildagliptin Impurity 25
|
C7H10N2O2
|
|
138402-33-2
|
5-(4'-(bromomethyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole
|
C14H11BrN4
|
|
162050-42-2
|
3-butyl-3-hydroxy-2-benzofuran-1-one
|
C12H14O3
|
|
250685-44-0
|
8-(1-NAPHTHALENYLMETHYL)-4-OXO-1-PHENYL-1,3,8-TRIAZASPIRO[4.5]DECANE-3-ACETIC ACID, METHYL ESTER
|
C27H29N3O3
|
|
871829-90-2
|
4-CYCLOPROPOXYPHENYLBORONIC ACID
|
C9H11BO3
|
|
1151944-57-8
|
(Z)-2-(5-benzylidene-4-oxo-2-thioxothiazolidin-3-yl)acetic acid
|
C12H9NO3S2
|
|
4548-78-1
|
Isopentylmagnesium bromide solution 2 in diethyl ether
|
C5H11BrMg
|
|
1380500-88-8
|
Methyltetrazine-Acid
|
C11H10N4O2
|
|
913287-21-5
|
6-CHLORO-PYRIDINE-2-SULFONYL CHLORIDE
|
C5H3Cl2NO2S
|
|
62978-52-3
|
Melphalan Methyl Ester HCl
|
C14H21Cl3N2O2
|
|
166527-00-0
|
7-DesMethyl-3-hydroxyagoMelatine
|
C14H15NO3
|
|
4237-93-8
|
ADRENOCORTICOTROPIC HORMONE, FRAGMENT 11-24
|
C77H134N24O16
|
|
906673-30-1
|
2-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]Benzonitrile
|
C14H10BNO3
|
|
1026042-12-5
|
Candesartan Cilexetil Methoxy Analogue
|
C32H32N6O6
|
|
166821-88-1
|
2-[2-(BROMOMETHYL)PHENYL]-5,5-DIMETHYL-1,3,2-DIOXABORINANE
|
C12H16BBrO2
|
|
1797117-23-7
|
ROBMDUUOTVWJEL-UHFFFAOYSA-N
|
C19H24BrNO3
|
|
1809286-36-9
|
4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid ethyl ester
|
C19H17NO4
|
|
1231220-79-3
|
LY2828360
|
C22H27ClN6O
|
|
160036-44-2
|
(2S)-2-{2-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)acetamido]acetamido}-3-phenylpropanoic acid
|
C28H27N3O6
|
|
4596-39-8
|
4-(2-CHLOROACETAMIDO)BENZOIC ACID
|
C9H8ClNO3
|
|
473717-08-7
|
9,10-Bis[N-(2-naphthyl)anilino]anthracene
|
C46H32N2
|
|
36281-96-6
|
3-BENZYLOXYPHENYLMAGNESIUM BROMIDE, 1M &
|
C13H11BrMgO
|
|
903130-23-4
|
ETHYL 3-CHLORO-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRAZINE-2-CARBOXYLATE
|
C9H12ClN3O2
|
|
85248-93-7
|
Pseudomonic Acid D
|
C26H42O9
|
|
646051-52-7
|
Bis(4-fluorobenzyl)aMine
|
C14H13F2N
|
|
3215-41-6
|
9H-carbazole-3,6-dicarboxylic acid
|
C14H9NO4
|
|
1270153-04-2
|
Melphalan Impurity B
|
C13H18N2O3
|
|
1470249-17-2
|
2,4,8-trichloropyrido[3,4-d]pyrimidine
|
C7H2Cl3N3
|
|
81528-48-5
|
Methyl 4-aMino-5-Methylthiophene-3-carboxylate
|
C7H9NO2S
|
|
28694-94-2
|
Methyl 2-(4-aMino-3-nitrophenyl)acetate
|
C9H10N2O4
|
|
1394382-56-9
|
PYRIDINE-2,6-BIS(CARBOXIMIDAMIDE) DIHYDROCHLORIDE
|
C7H10ClN5
|
|
19301-35-0
|
5-Hydroxythionaphthene
|
C8H6OS
|
|
59481-27-5
|
[TYR11 ]-SOMATOSTATIN
|
C76H104N18O20S2
|
|
66956-74-9
|
1-(tetrahydro-2H-pyran-4-yl)ethanol
|
C7H14O2
|
|
1092352-99-2
|
Anagrelide impurity 4
|
C10H6Cl3N3O
|
|
2289728-58-9
|
Enpp-1-IN-1
|
C17H17N3O3S
|
|
1797894-80-4
|
Bupivacaine EP Impurity C
|
C14H17NO
|
|
90984-99-9
|
ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR
|
C119H189N43O36S2
|
|
201935-41-3
|
2-chloro-5-Methoxybenzene-1-sulfonyl chloride
|
C7H6Cl2O3S
|
|
1192-08-1
|
3-Methylcyclobutan-1-one
|
C5H8O
|
|
1352396-67-8
|
2-chloro-7H-Pyrrolo[2,3-d]pyriMidine-5-carboxylic acid Methyl ester
|
C8H6ClN3O2
|
|
1228561-27-0
|
(1R)-5-BROMOINDANYLAMINE
|
C9H10BrN
|
|
1246929-02-1
|
Eltrombopag Impurity 1
|
C25H23N5O3
|
|
141626-57-5
|
N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)-benzoyl)benzofuran-5-yl)-N-(methylsulfonyl)methanesulfonamide
|
C32H46N2O7S2
|
|
685523-06-2
|
Perindopril-N-desethylpentanoate
|
C12H20N2O3
|
|
5443-31-2
|
4,6-DIAMINO-2-METHYL-QUINOLINE
|
C10H11N3
|
|
4423-94-3
|
2-ETHYLCYCLOHEXANONE
|
C8H14O
|
|
2446480-97-1
|
1H-Pyrazolo[3,4-d]pyrimidine, 6-(4-cyclopropyl-6-methoxy-5-pyrimidinyl)-1-[[4-[1-(1-methylethyl)-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-
|
C27H25F3N8O
|
|
307531-95-9
|
Etoricoxib Impurity M
|
C15H15NO2S
|
|
433228-88-7
|
Benzenemethanol, 3,5-difluoro-alpha-methyl-, (alphaR)- (9CI)
|
C8H8F2O
|
|
389868-12-6
|
AC-GLU-GLU-VAL-VAL-ALA-CYS-PNA
|
C34H50N8O13S
|
|
888721-65-1
|
1-(4-fluorophenyl)-6-Methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid
|
C13H10FNO3
|
|
26254-35-3
|
5-bromoacenaphthylene-1,2-dione
|
C12H5BrO2
|
|
400024-12-6
|
AMlodipine IMpurity E Maleate
|
C25H31ClN2O9
|
|
692732-03-9
|
Benzenemethanol, 3,5-difluoro-alpha-methyl-, (alphaS)- (9CI)
|
C8H8F2O
|
|
2289690-31-7
|
MYCi361
|
C26H16ClF9N2O2
|
|
2170771-53-4
|
Piperacillin impurity 8/Piperacillin Dimer impurity 3
|
C46H54N10O14S2
|